Lupin announced the completion of the Good Manufacturing
Practices (GMP) inspection of its Goa facility (Unit - I & II), by the Pharmaceutical and Medical Devices Agency
(PMDA), Japan. The inspection was conducted between 24 September 2019 and 27 September 2019.
The PMDA inspection closed with no critical or major observations.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
